Minghui Zhang

Dr. Minghui Zhang

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2022 in Structure
Verified
Journal Article
Closed access
MZMinghui Zhang
Minghui Zhang
LZLaixing Zhang
Laixing Zhang
RGRunyu Guo
Runyu Guo
CXChun Xiao
Chun Xiao
JYJian Yin
Jian Yin
MYMaojun Yang
Maojun Yang

27 September 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
YZYitang Zhang
Yitang Zhang
MCMaofei Chen
Maofei Chen
XCXudong Chen
Xudong Chen
MZMinghui Zhang
Minghui Zhang
JYJian Yin
Jian Yin
MYMaojun Yang
Maojun Yang
The 2-oxoglutarate dehydrogenase complex (OGDHc) orchestrates a critical reaction regulating the TCA cycle. Although the structure of each OGDHc subunit has been solved, the architecture of the intact complex and inter-subunit interactions still remain unknown. Here we report the assembly of native, intact OGDHc from Sus scrofa heart tissue using cryo-electron microscopy (cryo-EM), cryo-electron tomography (cryo-ET), and subtomogram averaging (STA) to discern native structures of the whole complex and each subunit. Our cryo-EM analyses revealed the E2o cubic core structure comprising eight homotrimers at 3.3-Å resolution. More importantly, the numbers, positions and orientations of each OGDHc subunit were determined by cryo-ET and the STA structures of the core were resolved at 7.9-Å with the peripheral subunits reaching nanometer resolution. Although the distribution of the peripheral subunits E1o and E3 vary among complexes, they demonstrate a certain regularity within the position and orientation. Moreover, we analyzed and validated the interactions between each subunit, and determined the flexible binding mode for E1o, E2o and E3, resulting in a proposed model of Sus scrofa OGDHc. Together, our results reveal distinctive factors driving the architecture of the intact, native OGDHc.

Verified
Journal Article
Open access
PDF file
MZMinghui Zhang
Minghui Zhang
BWBowen Wu
Bowen Wu
JGJinke Gu
Jinke Gu
The mitochondrial serine β-lactamase-like protein LACTB has emerged as a critical regulator in cancer biology, distinguished by its unique structural and functional attributes. Defined by its conserved penicillin-binding proteins and β-lactamases (PBP-βLs) domain and SXXK catalytic motif, LACTB demonstrates properties distinct from its prokaryotic homologs, including the ability to polymerize into filaments. These structural characteristics enable LACTB to modulate mitochondrial organization and enzymatic activity, influencing lipid metabolism and indirectly affecting cellular proliferation. Importantly, the expression and functional roles of LACTB exhibit cancer-type-specific variation, underscoring its dual function as both a tumor suppressor and an oncogene. Decreased LACTB expression is associated with poor clinical outcomes in cancers such as breast cancer, lung cancer, and colorectal cancer, while specific mutations and regulatory mechanisms have been linked to its oncogenic activity in osteosarcoma and pancreatic adenocarcinoma. Mechanistically, LACTB regulates key processes in cancer progression, including mitochondrial dynamics, epithelial–mesenchymal transition (EMT), and cell death pathways. This duality highlights LACTB as a promising therapeutic target and underscores its relevance in advancing precision oncology strategies. This review provides a comprehensive analysis of expression level, structure–function relationships, and the diverse roles of LACTB in oncogenesis, underscoring its promise as a focal point for precision cancer therapies.

21 August 2026 in Protein & Cell
Verified
Journal Article
Open access
MZMinghui Zhang
Minghui Zhang
BWBowen Wu
Bowen Wu
ZLZhouzhu Liang
Zhouzhu Liang
YSYintao Su
Yintao Su
HPHuacai Peng
Huacai Peng
JGJinke Gu
Jinke Gu